Barclays’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-50,100
Closed -$3.84M – 7043
2019
Q1
$3.84M Buy
+50,100
New +$2.78M ﹤0.01% 1894

Other funds holding GH

Barclays's GH Position: Q3 2026 in Review

Barclays increased its Guardant Health (GH) stake by 12% in Q3 2026, buying an estimated $3.03M and bringing the position to 169,754 shares worth $30.3M. The position accounts for 0.01% of the portfolio, ranked #1021.

Barclays first reported a position in GH in Q4 2018 and has held it in 32 quarters since. The position peaked at $34.3M in Q4 2025. 671 funds tracked by Wall St. Rank hold GH as of Q3 2026.

  • Barclays held 169,754 shares of Guardant Health worth $30.3M as of Q3 2026.
  • Barclays bought 18,550 Guardant Health shares in Q3 2026, an estimated $3.03M.
  • Guardant Health made up 0.01% of Barclays's portfolio in Q3 2026, its #1021 holding.
  • Barclays first reported a position in Guardant Health in Q4 2018 and has held it in 32 quarters since.
  • Barclays's Guardant Health position peaked at $34.3M in Q4 2025.
  • 671 funds tracked by Wall St. Rank held Guardant Health as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.